Alcohol for seizure induction in the epilepsy monitoring unit.

Alcohol Epilepsy monitoring unit Induction techniques

Journal

Epilepsy & behavior : E&B
ISSN: 1525-5069
Titre abrégé: Epilepsy Behav
Pays: United States
ID NLM: 100892858

Informations de publication

Date de publication:
08 Dec 2023
Historique:
received: 09 10 2023
revised: 17 11 2023
accepted: 28 11 2023
medline: 10 12 2023
pubmed: 10 12 2023
entrez: 9 12 2023
Statut: aheadofprint

Résumé

Seizure induction techniques are used in the epilepsy monitoring unit (EMU) to increase diagnostic yield and reduce length of stay. There are insufficient data on the efficacy of alcohol as an induction technique. We performed a retrospective cohort study using six years of EMU data at our institution. We compared cases who received alcohol for seizure induction to matched controls who did not. The groups were matched on the following variables: age, reason for admission, length of stay, number of antiseizure medications (ASM) at admission, whether ASMs were tapered during admission, and presence of interictal epileptiform discharges. We used both propensity score and exact matching strategies. We compared the likelihood of epileptic seizures and nonepileptic events in cases versus controls using Kaplan-Meier time-to-event analysis, as well as odds ratios for these outcomes occurring at any time during the admission. We analyzed 256 cases who received alcohol (median dose 2.5 standard drinks) and 256 propensity score-matched controls. Cases who received alcohol were no more likely than controls to have an epileptic seizure (X Alcohol was not an effective induction technique in the EMU. This finding has implications for counseling patients with epilepsy about the risks of drinking alcohol in moderation in their daily lives.

Identifiants

pubmed: 38070406
pii: S1525-5050(23)00491-2
doi: 10.1016/j.yebeh.2023.109572
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109572

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Brian E Emmert (BE)

Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia PA, USA. Electronic address: Brian.emmert@pennmedicine.upenn.edu.

Kevin Xie (K)

Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA; Center for Neuroengineering & Therapeutics, University of Pennsylvania, Philadelphia, PA, USA.

Erin C Conrad (EC)

Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia PA, USA; Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA; Center for Neuroengineering & Therapeutics, University of Pennsylvania, Philadelphia, PA, USA.

Nina J Ghosn (NJ)

Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA; Center for Neuroengineering & Therapeutics, University of Pennsylvania, Philadelphia, PA, USA.

Kristie Bauman (K)

Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia PA, USA.

Jacob Korzun (J)

Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia PA, USA.

Catherine V Kulick-Soper (CV)

Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia PA, USA.

Omer Naveed (O)

Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia PA, USA.

Nicole Hartmann (N)

Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia PA, USA.

Joshua J LaRocque (JJ)

Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia PA, USA.

Taneeta Mindy Ganguly (T)

Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia PA, USA.

James J Gugger (JJ)

Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia PA, USA; Center for Neuroengineering & Therapeutics, University of Pennsylvania, Philadelphia, PA, USA.

Ramya Raghupathi (R)

Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia PA, USA.

Michael A Gelfand (MA)

Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia PA, USA.

Kathryn A Davis (KA)

Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia PA, USA; Center for Neuroengineering & Therapeutics, University of Pennsylvania, Philadelphia, PA, USA.

Saurabh R Sinha (SR)

Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia PA, USA.

Brian Litt (B)

Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia PA, USA; Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA; Center for Neuroengineering & Therapeutics, University of Pennsylvania, Philadelphia, PA, USA.

Russell T Shinohara (RT)

Penn Statistics in Imaging and Visualization Center (PennSIVE), Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia PA, USA; Center for Biomedical Image Computing and Analytics, Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia PA, USA.

Colin A Ellis (CA)

Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia PA, USA.

Classifications MeSH